Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1412 of 5804
-
PET scans probe link between brain inflammation and Alzheimer's damage
Knowledge-focused OngoingThis study aims to analyse, in vivo, the interplay between microglial activation and tau pathology in Alzheimer's disease (AD) using \[18F\]-DPA-714 and \[18F\]-Ro948 tracers by Position Emission Tomography (PET), and their consequences on synaptic density using \[11C\]-UCB-J, a …
Phase: NA • Sponsor: Centre Hospitalier St Anne • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Simple hygiene steps could curb cholera outbreaks
Prevention Recruiting nowObjective: The investigators objective is to develop and evaluate the effectiveness of a case area targeted water, sanitation, and hygiene (WASH) intervention in reducing cholera infections and increasing sustained WASH behaviors in transmission hotspots in a ring around cholera …
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis first-in-human (FIH) dose-escalation and dose-validation/expansion study will assess KO-2806, a farnesyltransferase inhibitor (FTI), as a monotherapy and in combination, in adult patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New pill takes on tough cancers: early trial launches
Disease control Recruiting nowThis is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers.
Phase: PHASE1, PHASE2 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Mind-Reading brain chip could give voice to the voiceless
Knowledge-focused Recruiting nowThe purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.
Phase: NA • Sponsor: Leigh R. Hochberg, MD, PhD. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Eye injection could replace corneal transplants for swelling
Disease control CompletedThe goal of this clinical trial is to compare different doses of AURN001 in patients with corneal edema secondary to corneal endothelial dysfunction. The main questions the clinical trial aims to answer are whether AURN001 effective and safe. Participants will receive a single in…
Phase: PHASE1, PHASE2 • Sponsor: Aurion Biotech • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Brain pacemaker trial aims to lift severe depression
Disease control Recruiting nowThe goal of this clinical trial is to demonstrate the feasibility and safety of deep brain stimulation in treatment resistant depression. The main questions it aims to answer are: * Is deep brain stimulation effective in treating treatment resistant depression? * Does deep brain…
Phase: PHASE1 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
DNA-Guided drug switch could improve GIST treatment
Disease control Recruiting nowThe purpose of this research is to test if mutations (changes in DNA) in exons (segment of DNA or RNA containing information that has the instructions for making proteins) in the KIT gene can be used to predict the body's response to standard of care treatment.
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 26, 2026 15:13 UTC
-
Diet overhaul may cut colon cancer risk in obese adults with polyps
Disease control Recruiting nowThis study is a 6-month randomized controlled trail of diet modification designed to reduce chronic inflammation and reverse metabolic dysfunction among obese individuals with one or more polyps found at a colonoscopy screening. We also will recruit an at least overweight partner…
Phase: NA • Sponsor: University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New stent aims to keep leg arteries open longer
Disease control Recruiting nowThe objective of this prospective, multicenter, randomized, controlled clinical trial is to demonstrate the superiority of the VBX Device for primary patency when compared to bare metal stenting in complex iliac occlusive disease.
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug duo aims to halt advanced cancers
Disease control Recruiting nowThis is a randomized, Open-label, Phase Ib/IIa study to evaluate the efficacy and safety of SPH4336 monotherapy or in combination with Cadonilimab in the patients with selected advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could a light cap help kids with autism? new trial aims to find out.
Symptom relief Recruiting nowThis study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales…
Phase: NA • Sponsor: State University of New York - Upstate Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New biologic KER-012 shows promise for Hard-to-Treat lung condition
Disease control TerminatedStudy KER-012-A201 is Phase 2, double-blind, randomized, placebo-controlled study to determine the efficacy and safety of KER-012 compared to Placebo in adults with PAH (WHO Group 1 PH) on stable background PAH therapy. The study is divided into the Screening Period, Treatment Pe…
Phase: PHASE2 • Sponsor: Keros Therapeutics, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Shoulder surgery showdown: which fix keeps your joint in place?
Disease control OngoingThe primary objective of the study is to evaluate the functional shoulder recovery of patients with recurrent shoulder dislocations at 24 months when treated with either arthroscopic capsuloligamentous repair (Bankart Procedure +/- Remplissage) or coracoid transfer (Latarjet proc…
Phase: NA • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Cancer drug dasatinib tested to shrink hidden HIV reservoirs
Disease control CompletedThe goal of this clinical trial is to evaluate the safety, tolerability and Impact of low dose Dasatinib in People with Human Immunodeficiency Virus (PWH) on suppressive Combined Antiretroviral Therapy (cART),. The main question it aims to answer are: * How safe and tolerable i…
Phase: PHASE2 • Sponsor: Fundació Institut Germans Trias i Pujol • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New program aims to tackle high blood pressure and diabetes in underserved communities
Disease control Recruiting nowThe LINKED- HEARTS Program is a multi-level project that intervenes at the practice level by linking home blood pressure monitoring (HBPM) with a telemonitoring platform (Sphygmo). The program incorporates team-based care by including community health workers (CHWs) and pharmacis…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a pill replace IV therapy for MDS? new study investigates
Disease control OngoingThis is an Open-Label, Crossover, Pharmacokinetic and Efficacy Bridging Study of Oral ASTX727 versus IV Decitabine in Chinese Subjects with Myelodysplastic Syndromes
Phase: PHASE1, PHASE2 • Sponsor: Otsuka Beijing Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Targeted drug shows promise for Hard-to-Treat prostate cancer
Disease control OngoingThis phase II trial tests how well M1774 works in treating patients with prostate cancer that does not respond to treatment (refractory) and that has a mutation in the gene responsible for making the speckle type BTB/POZ protein (SPOP). M1774 may stop the growth of tumor cells by…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a website help cancer patients avoid unwanted aggressive treatments?
Symptom relief CompletedThe goal of this clinical trial is to determine whether a web-based advance care planning (ACP) intervention can reduce preferences for aggressive life-sustaining treatments among patients with advanced cancer. The main questions it aims to answer are: * Does a web-based ACP in…
Phase: NA • Sponsor: Tri-Service General Hospital (TSGH) • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New online therapy aims to help teens manage emotions and reduce mental health symptoms
Symptom relief Recruiting nowMental health problems in youth are a global problem, causing incalculable suffering in youth and families, harming long-term prospects of youths, and creating substantial economic costs to society. The overall objective of this study is to build an evidence base for a highly sc…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC